$50,000 of CABOT CORPORATION lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Clean Air Issues"
You can find more data on corporate lobbying on Quiver Quantitative.
CBT Hedge Fund Activity
We have seen 161 institutional investors add shares of CBT stock to their portfolio, and 137 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 398,025 shares (+41.2%) to their portfolio in Q1 2026, for an estimated $29,975,262
- PROSHARE ADVISORS LLC added 349,861 shares (+2125.5%) to their portfolio in Q1 2026, for an estimated $26,348,031
- UBS GROUP AG removed 326,725 shares (-53.2%) from their portfolio in Q1 2026, for an estimated $24,605,659
- FULLER & THALER ASSET MANAGEMENT, INC. removed 295,062 shares (-12.6%) from their portfolio in Q1 2026, for an estimated $22,221,119
- AMERICAN CENTURY COMPANIES INC added 217,569 shares (+10.8%) to their portfolio in Q1 2026, for an estimated $16,385,121
- JONES FINANCIAL COMPANIES LLLP added 213,825 shares (+21276.1%) to their portfolio in Q1 2026, for an estimated $16,103,160
- WELLINGTON MANAGEMENT GROUP LLP removed 185,397 shares (-4.9%) from their portfolio in Q1 2026, for an estimated $13,962,248
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CBT Price Targets
Multiple analysts have issued price targets for $CBT recently. We have seen 4 analysts offer price targets for $CBT in the last 6 months, with a median target of $88.0.
Here are some recent targets:
- John Roberts from Mizuho set a target price of $90.0 on 06/25/2026
- Peter Osterland from Truist Securities set a target price of $98.0 on 06/08/2026
- Jeffrey Zekauskas from JP Morgan set a target price of $70.0 on 05/13/2026
- Joshua Spector from UBS set a target price of $86.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
